[1]
Xiao, Y. et al. 2025. Alectinib and SALL4-Targeted Fatty Acid Oxidation: A Strategy to Combat Oxaliplatin Resistance in Gastric Cancer. Turkish Journal of Gastroenterology. 36, 12 (Jun. 2025), 813–821. DOI:https://doi.org/10.5152/tjg.2025.24495.